Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

FOLFIRI-bevacizumab regimen

View Patient Information
A regimen consisting of bevacizumab, fluorouracil, irinotecan and leucovorin that may be used in the treatment of appendiceal adenocarcinoma, colorectal cancer, and small bowel adenocarcinoma.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:FOLFIRI-Avastin regimen
FOLFIRI/bevacizumab regimen
folinic acid-fluorouracil-irinotecan-bevacizumab regimen
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search